The function of the Vibrio 7 th pandemic island-1 (VSP-1) in cholera pathogenesis has remained obscure. Utilizing chromatin immunoprecipitation sequencing and RNA sequencing to map the regulon of the master virulence regulator ToxT, we identify a TCP island-encoded small RNA that reduces the expression of a previously unrecognized VSP-1-encoded transcription factor termed VspR. VspR modulates the expression of several VSP-1 genes including one that encodes a novel class of dinucleotide cyclase (DncV), which preferentially synthesizes a previously undescribed hybrid cyclic AMP-GMP molecule. We show that DncV is required for efficient intestinal colonization and downregulates V. cholerae chemotaxis, a phenotype previously associated with hyperinfectivity. This pathway couples the actions of previously disparate genomic islands, defines VSP-1 as a pathogenicity island in V. cholerae, and implicates its occurrence in 7 th pandemic strains as a benefit for host adaptation through the production of a regulatory cyclic di-nucleotide.
INTRODUCTION
The causative agent of cholera, Vibrio cholerae, requires a multifaceted regulatory network involving a hierarchy of transcription factors, small RNAs (sRNAs), and signaling molecules to ensure the proper spatial and temporal activation of virulence factor expression (Ritchie and Waldor, 2009) . Often referred to as the master virulence regulator, ToxT directly activates expression of several essential virulence genes including those that encode cholera toxin and an essential colonization factor, the toxin coregulated pilus (TCP) (Lowden et al., 2010) . Although ToxT is essential for V. cholerae pathogenesis, the complete spectrum of genes it regulates is unknown (DiRita et al., 1991; Weber and Klose, 2011) .
ToxT is encoded on the TCP island, a chromosomal segment that encodes many virulence-associated genes found in all pandemic strains of V. cholerae (Faruque and Mekalanos, 2003) . All pandemic strains also carry the CTX prophage encoding the genes for cholera toxin (ctxAB) as well as the genomes for satellite phages (Hassan et al., 2010) . Two V. cholerae biotypes account for the majority of all recorded cholera pandemics. The classical biotype is thought to have caused the first six pandemics (Kaper et al., 1995; Pollitzer, 1959) but was replaced by the 7 th pandemic El Tor biotype approximately 50 years ago (Faruque and Mekalanos, 2003) . 7 th pandemic El Tor strains are genetically distinguishable from classical strains by the presence of two genomic islands, Vibrio 7 th pandemic island-1 (VSP-1) and VSP-2 (Dziejman et al., 2002) . These islands are consistently found in clinical El Tor isolates and are thought to be responsible, at least in part, for the success of the 7 th pandemic clone (Dziejman et al., 2002; Grim et al., 2010; Rahman et al., 2008; Taviani et al., 2010) . However, validation of predicted functions for most open reading frames (ORFs) on these islands or evidence for the contribution of VSP-1 or VSP-2 to environmental or host adaptation is lacking (Dziejman et al., 2002) . Furthermore, it is unknown how VSP-1 and VSP-2 genes are regulated and whether their products act as isolated modules or integrate into pathways with the ancestral genome or accessory-encoded elements such as the TCP island and CTX prophage.
Cyclic di-nucleotides act as intracellular signals, modulating a range of cellular activities (Gomelsky, 2011) . In Gram-negative bacteria, cyclic di-GMP (c-di-GMP) is a major regulator of biofilms (Tischler and Camilli, 2004) and flagellum biosynthesis (Lim et al., 2007) . Coordination between c-di-GMP and transcription was clearly shown in V. cholerae where c-di-GMP directly binds to and modulates the activity of transcriptional regulator VpsT (Krasteva et al., 2010) and upregulates another virulence regulator AphA (Srivastava et al., 2011) . Gram-positive bacteria also produce cyclic di-AMP (c-di-AMP). Listeria monocytogenes secretes c-di-AMP, which serves as a recognition signal for the mammalian innate immune system (Woodward et al., 2010) , and Staphylococcus aureus uses c-di-AMP to manage cell membrane stress (Corrigan et al., 2011) . Surprisingly, cyclic di-nucleotides other than c-di-GMP have not been reported in Gram-negative bacteria including V. cholerae.
Here, we use massively parallel DNA-sequencing technologies to identify the complete regulon of ToxT. Combining transcriptome profiling (RNA sequencing [seq] ) with binding location analysis (chromatin immunoprecipitation sequencing [ChIPseq]), we identify all genes directly regulated by ToxT in vivo as well as several indirectly regulated pathways. From this analysis we identified a TCP-encoded sRNA that downregulates expression of a novel VSP-1 encoded transcription factor, which in turn controls the expression of several VSP-1 genes including one that is required for efficient intestinal colonization by V. cholerae. We show that the gene product that stimulates intestinal colonization encodes a di-nucleotide cyclase (DncV) that preferentially synthesizes a hybrid cyclic AMP-GMP molecule. Furthermore, the activity of this enzyme strongly influences the chemotactic behavior of V. cholerae, thereby associating the action of this enzyme with a process known to influence infectivity and the intestinal colonization process.
RESULTS
ToxT Directly Activates Genes Only within the TCP Island and CTX Prophage and Indirectly Regulates Several Other Metabolic Pathways ToxT expression increases 500-1,000-fold when V. cholerae colonizes a mammalian host (Mandlik et al., 2011) . To simulate this expression change, we cloned ToxT into a plasmid under the control of an inducible promoter in V. cholerae El Tor strain C6706, an isolate from the 7 th pandemic that extended into Peru in 1991 (Mandlik et al., 2011) . Using this system, we increased ToxT expression $1,000-fold following induction (Table 1) . We The location of ToxT peaks was determined from four independent samples (FDR < 0.001). The range of the 5 0 and 3 0 end coordinate is shown. A ChIP peak is associated with a gene if it overlaps the start codon. previously described a method to perform ChIP in combination with massively parallel sequencing (ChIP-seq) to identify genome-wide binding locations of transcription factors in V. cholerae (Davies et al., 2011) . Applying this method, we identified all ToxT-binding locations (ChIP peaks) in the V. cholerae genome under our test conditions ( Figure 1A ; Table 1 ).
From each ChIP-seq run we aligned an average of 1.4 million short $36 base reads to the published N16961 V. cholerae genome (Heidelberg et al., 2000) . The alignments gave a total average coverage of 13-fold for chromosome 1 and 8-fold coverage of chromosome 2. This depth of coverage allowed us to use a low false discovery rate (FDR) cutoff of 0.001% to call ToxT ChIP peaks. ChIP peaks are called when the sequence coverage of a given genomic region in the experimental sample exceeds the control sample at a rate specified by the FDR (see Experimental Procedures). We compared the peak lists generated from four samples and set a limit that a peak must be called in all experiments to be considered a ToxT-binding site (Hå ndstad et al., 2011) . We then associated a ToxT peak with a gene if the peak overlapped the first codon of the respective gene ( Figure 1A ; Table 1 ).
To validate ToxT transcriptional control of associated genes, we briefly induced ToxT expression (10 min), isolated and sequenced total mRNA (RNA-seq), and compared the transcriptome profile to a control strain carrying an empty expression vector. We reasoned that direct regulatory targets of ToxT would show the most rapid transcriptional response to brief ToxT induction. Comparison of the transcriptome response with our ChIP-seq analysis uniformly showed strong transcriptional upregulation of the same genes we had associated with ToxT ChIP peaks, supporting our conclusion that these genes are directly activated by ToxT ( Figure 1A ; Table 1 ). These results provide the first detailed in vivo map of ToxT-binding locations in conjunction with ToxT-driven expression alteration.
A ToxT-binding motif (Toxbox) has been previously proposed based on the sequences of all known ToxT-binding sites (Withey and DiRita, 2006) . This Toxbox consensus matches to thousands of potential sites across the V. cholerae genome. Thus, we were surprised when our analysis identified only six ToxT ChIP peaks (Table 1) . Interestingly, all ToxT ChIP peaks are located in the TCP island and CTX prophage. Importantly, five of the six ChIP peaks we identified overlap all ToxT-binding sites previously identified by direct in vitro ToxT footprinting assays or inferred from genetic analysis (Richard et al., 2010; Withey and DiRita, 2005a , 2005b , validating our technique to identify authentic ToxT-binding locations. Three ToxT ChIP peaks lay between divergently transcribed gene pairs aldA-1/tagA, tcpI/ tcpP, and acfA/acfD. Each of these genes is known to have its own associated ToxT-binding motif(s) (Richard et al., 2010; Withey and DiRita, 2005a , 2005b ; however, resolving closely spaced binding sites using ChIP-seq is challenging and often results in one overlapping ChIP peak. The confinement of ToxT binding to the TCP island and CTX prophage, despite its predicted statistically common consensus binding motif, suggests that factors in addition to nucleotide sequence may influence the stringency of DNA binding selection by ToxT in vivo.
We also identified several additional genes not directly associated with ToxT ChIP peaks that were differentially regulated following ToxT induction (Figure 1 ; see Table S1 available online). These genes encode components of pathways involved in iron transport, amino acid metabolism, transcriptional regulation, pilus assembly, and carbon transport and metabolism (Figure 1 ). Interestingly, whereas direct regulatory targets of ToxT were strongly upregulated, the majority of these indirectly regulated genes were downregulated. Among the pathways impacted, iron transport exhibited the largest concerted effect with 19 genes downregulated >5-fold ( Figure 1 ; Table S1 ). This includes pathways for the production of vibriobactin, hemin, and iron III transporters as well as TonB, a protein that supports transport. Conversely, the largest upregulation was from genes involved in maltose transport ( Figure 1A ; Table S1 ). Specifically, the maltose ABC transporter and the maltoporin (ompS) all showed increased expression >12-fold (Table S1 ). It is unclear how ToxT indirectly impacts the expression of these genes. ToxT does directly increase expression of the transcription factor TcpP encoded by the TCP island; thus, it is possible that TcpP directly affects some genes including the eight additional transcription factors indirectly affected by ToxT ( Figure 1A ; Table 1 ). TcpP and these transcriptional regulators may drive changes observed in the ToxT transcriptome profile.
ToxT Directly Regulates the Expression of the TCP Island-Encoded sRNA TarB We identified a 6 th ToxT ChIP peak located in an intergenic region of the Tcp island between genes VC0845 and VC0846 ( Figure 1B ). Quantitative PCR (qPCR) validated our sequencing data showing that the enrichment of ToxT ChIP DNA at this intergenic site was similar to that of ToxT-binding sites upstream of ctxA and tcpP ( Figure 1C ). Alignment of RNA-seq reads from ToxT expressing V. cholerae with the region between VC0845 (B) Schematic of the 6 th ToxT ChIP peak site in the Tcp island between VC0845 and VC0846. The heat map shows enrichment (red) of sequenced reads at ToxT ChIP peak. Below, alignment of RNA-seq reads shows the predicted sRNA outlined by the black box. RNA-seq reads colored red align to the reverse strand of the genome, whereas reads colored green align to the forward strand. The predicted sequence of the sRNA is shown at the top in uppercase font from 5 0 to 3 0 . The nucleotides in bold highlight a rho-independent hairpin terminator predicted by the ARNold program server. (C) ToxT ChIP enrichment of the promoter regions of ctxA, tcpA, and 6 th ToxT ChIP peak was determined by qPCR relative to sample DNA input. Enrichment of a non-ToxT-dependent promoter of VC1141 is shown as a control. Significance was determined by t test relative to the VC1141 promoter: ***p < 0.001; ****p < 0.0001. Mean with standard error of the mean (SEM) is shown.
(D) Northern blot of RNA from indicated strains probed for the presence of the sRNA (TarB) as predicted by RNA-seq alignment (top panel). The size markers of a ssRNA ladder are indicated. The same samples were probed for 5S rRNA as a loading control (bottom panel).
(E) qPCR analysis of the effect of TarB on VC0177 (VspR) expression levels in V. cholerae WT strains C6706 and E7946 following expression of ToxT from a plasmid. Expression for each sample was determined relative to 16S rRNA, and at least three independent replicates were tested. Fold changes are normalized relative to expression in the WT strain. Significance was determined by t test relative to the WT strain: **p < 0.01; ****p < 0.0001. Mean with SEM is shown. See also Table S1 .
and VC0846 revealed a putative sRNA on the reverse strand overlapping the new ToxT-binding site ( Figure 1B ). The sRNA had a clear 5 0 start at coordinate 911308 and appeared to terminate at coordinate 911239 following a predicated rho-independent hairpin terminator ( Figure 1B) . Northern blotting using a probe against this region identified a sRNA that was strongly induced by ToxT ( Figure 1D ). The sRNA migrated slightly below the 80 nucleotide (nt) ssRNA marker agreeing with the 69 nt size predicted from RNA-seq read alignments. An identical sRNA has recently been identified (Bradley et al., 2011) , and thus, we called this sRNA ToxT-activated sRNA B (TarB). TarB has also been shown to be strongly upregulated in V. cholerae during infection of an animal model (Mandlik et al., 2011) .
TarB Represses the Expression of a V. cholerae VSP-1 Gene The small regulatory protein Hfq binds sRNAs, stabilizing and assisting them for targeting and promoting degradation of specific mRNAs (Brennan and Link, 2007) . TarB levels were greatly decreased in a V. cholerae C6706 hfq::Tn mutant (Figure 1D) , suggesting that TarB likely interacts with Hfq and thus may help to negatively regulate target mRNAs. We reasoned that if TarB negatively regulated a gene, the expression of the target gene should be higher in a DtarB strain compared to the wild-type (WT) when ToxT is expressed. We took a genetic approach to identify potential mRNA targets of TarB by using RNA-seq to compare the expression profiles of WT and DtarB strains expressing ToxT. We identified only two genes, VC0177 and VC2706, as having significantly increased expression levels in the DtarB strain, suggesting that expression of TarB may decrease their stability (VC0177 expression DtarB/WT = 21.5-fold, p < 1e À5 ; VC2706 expression DtarB/WT = 4.5-fold, p < 1e À5 ). Interestingly, the most strongly upregulated gene in the DtarB mutant, VC0177, is part of VSP-1. qPCR confirmed the RNA-seq analysis showing that VC0177 expression was significantly higher in the DtarB strain than the WT ( Figure 1E ). We also showed that this pathway was active in a second clinical El Tor strain, E7946 ( Figure 1E ). This indicates that the ToxTTarB-VC0177 pathway is not strain specific. However, TarB does appear to have a more profound effect on VC0177 in strain C6706 compared to E7946, suggesting some variability in the magnitude of the effect of this pathway in different strains. The interaction between TarB and VSP-1 encoded VC0177 is reminiscent of the coordinated control of the TCP island and prophage CTXF. Both VSP-1 and prophage CTXF are acquired horizontally and separately from the TCP island, yet genes from both VSP-1 and phage CTXF are ultimately regulated by TCP island-encoded ToxT. VC0177 expression formally joins the ToxT regulon through its dependence on ToxT-regulated TarB induction. This association suggests that the co-occurrence of at least VSP-1 in 7 th pandemic strains of V. cholerae may have been driven by its regulatory integration with other accessory elements (TCP and CTX) encoding pathogenic adaptation.
VC0177 Is a Transcription Factor that Represses
Several VSP-1 Genes Annotated as a hypothetical protein, VC0177 does not share sequence homology with known proteins by basic alignment searches (BLAST). However, HHPRED analysis (Biegert et al., 2006) , which uses protein structure prediction, indicates that VC0177 shares structural homology with metallo-regulator repressor proteins. Because ToxT directly regulates genes located predominantly in the island in which it is encoded, we reasoned that VC0177 might have similar restrictions and repress genes within VSP-1, which spans loci VC0175-VC0185. Agreeing with the predicted transcription repressor role for VC0177, we found that expression of four VSP-1 genes was significantly increased in a VC0177::Tn mutant ( Figure 2A ). Furthermore, we found that the expression of the same four genes was similarly affected in strains carrying an in-frame deletion of VC0177, indicating that the regulation control was not due to the transposon insertion ( Figure S1A ). To test whether VC0177 was directly involved in the regulation of these genes, we performed ChIP with VC0177 and assayed for enrichment in regions directly upstream of VC0177-repressed genes by qPCR. We identified enrichment of 5 0 untranslated regions (UTRs) directly upstream of VC0176, VC0178, VC0179, and VC0180, supporting a direct role for VC0177 as a transcriptional repressor of these genes ( Figure 2B ). Therefore, we called the product of VC0177 the V. cholerae 7 th pandemic regulator (VspR).
The TarB Regulatory Circuit and VSP-1 ORF VC0179 Influence V. cholerae Intestinal Colonization To determine if the TarB-VspR regulatory circuit is involved in pathogenesis, we used the infant mouse model to measure V. cholerae intestinal colonization. To our knowledge, the effect of genes in VSP-1 on intestinal colonization has not been investigated. We found that the V. cholerae C6706 DtarB mutant showed a significant decrease in ability to colonize the small intestine compared to the WT strain in competition assays ( Figure 2C ). Combining the DtarB deletion with a VC0177::Tn mutant rescued the DtarB-dependent colonization defect ( Figure 2C ). This suggests that TarB likely influences colonization by downregulation of the VC0177-encoded regulator VspR. Because expression of VC0178, VC0179, and VC0180 increased in the V. cholerae VC0177::Tn mutant strain, we tested V. cholerae transposon mutants disrupted in these genes for intestinal colonization defects. Remarkably, only disruption of VC0179 caused a significant defect in intestinal colonization ( Figure 2C ). An in-frame deletion mutant of VC0179 (DVC0179) also showed a similar in vivo colonization defect ( Figure 2C ). These results identify VC0179 as a direct target of VspR repression in VSP-1 and, thus, an indirect target of TarB-mediated induction.
TarB is well conserved among all sequenced strains of V. cholerae including the classical strain O395 even though classical strains lack VSP-1 and therefore lack VspR. Northern blots show that ToxT also induces TarB in an O395 strain (Figure 1D) ; however, we did not anticipate a critical in vivo role for TarB O395 due to the lack of VSP-1. Agreeing with this, we found that deletion of TarB does not affect O395 colonization of the infant mouse intestine in competition assays ( Figure 2C ). TarB may regulate additional genes in O395 strains that do not influence intestinal colonization.
During the preparation of this manuscript, another group published the presence of TarB in a different El Tor strain, E7946, as part of a genome-wide study identifying ToxT-induced sRNAs (Bradley et al., 2011) . Although agreeing with our observation, Bradley et al. also reported a variable colonization phenotype for a DtarB mutant in strain E7946 that depended on initial growth conditions of the bacterium. We found a consistent intestinal colonization defect of an E7946 DtarB mutant with our growth conditions ( Figure 2C ). This defect was less severe than in strain C6706, which may be due to the difference in downregulation of VspR by TarB between these strains ( Figure 1E ). Using a computational approach to identify TarB mRNA targets, Bradley et al. reported an $2-fold repression of colonization factor TcpF mRNA. The authors noted that repression of a colonization factor by a ToxT-activated sRNA was counterintuitive. In contrast we did not detect an effect on TcpF expression in our genetic approach to identify TarB targets but did show that TarB downregulates VspR expression $12-fold in strain E7946, indicating that the ToxT-TarB-VspR pathway is active in E7946 and not specific to strain C6706 ( Figure 1E ). Computational prediction indicates that TarB has a more favorable and a simpler base-pairing configuration with the 5 0 UTR of VspR than TcpF, providing an explanation as to why TarB regulates VspR more strongly ( Figures S1B and S1C ).
VC0179 Is the First Member of a New Family of Di-Nucleotide Cyclases
Disruption of VSP-1 encoded VC0179 caused a significant defect in intestinal colonization ( Figure 2C ). VC0179 is a hypothetical protein and does not share overall sequence homology with known proteins. HHPRED analysis shows that VC0179 shares spatial alignment of key active site residues found in 2 0 -5 0 -oligoadenylate synthetases (OAS1) and poly(A) polymerase, both of which are part of the nucleotidyl transferase superfamily (NTS) (Holm and Sander, 1995) (Figure S2 ). The placement of these active site residues in VC0179 matches the consensus sequence (G[G/S]x 9-13 Dx[D/E]) of the NTS (Holm and Sander, 1995) . OAS1 and poly(A) polymerase catalyze the polymerization of oligoadenylates from ATP (Hartmann et al., 2003) . The structural similarity with OAS1 and poly(A) polymerase suggested that VC0179 might act catalytically on ATP.
To test this hypothesis, we purified VC0179, incubated it with a-P 32 ATP, and separated the products on a denaturing polyacrylamide gel. VC0179 produced a single product that migrated slightly above the ATP precursor ( Figure 3A) . As a control, we mutated the aspartate residues of the predicted VC0179 Dx[D/E] catalytic center to alanine residues (D131A and D133A; Figure S2) and purified the mutant protein. When incubated with ATP, the D131A/D133A VC0179 mutant protein did not produce the VC0179 product from ATP ( Figure 3A) , indicating that activity from the WT protein is dependent upon the predicted NTS catalytic residues and is not due to a contaminate.
The product produced from ATP by VC0179 is insensitive to calf intestinal phosphatase (CIP), indicating that it does not contain 5 0 or 3 0 terminal phosphate groups ( Figure 3B ). The product is sensitive to snake venom phosphodiesterase and nuclease P1, indicating that it contains 3 0 -5 0 phosphate linkages ( Figure 3B ; data not shown). These results suggested that the VC0179 product was a cyclic nucleotide. High-performance liquid chromatography (HPLC) analysis showed that the VC0179 product eluted with the same retention time as a commercial c-di-AMP standard ( Figures 3F and 3G) . Furthermore, LCMS and MS/MS analysis showed that the VC0179 product and c-di-AMP have identical molecular masses and fragmentation fingerprint (Tables S2 and S3 ; Figures S3  and S4 ), confirming that VC0179 synthesizes c-di-AMP. To our knowledge, this is the first report of c-di-AMP synthesis by a Gram-negative bacterium enzyme and the first adenylate cyclase based on a non-DU147 protein domain structure (Rö mling, 2008) .
We tested the catalytic ability of VC0179 with additional nucleotides. We found that VC0179 is not active against dATP (data not shown). When incubated with GTP, VC0179 produces c-di-GMP ( Figure 3C ) that was confirmed by HPLC, LCMS, and MS/MS comparison with a commercial c-di-GMP standard ( Figures 3F, 3H , S3, and S4; Tables S2 and S3 ). Interestingly, both PAGE and HPLC analysis indicated more c-di-AMP production than c-di-GMP per unit time, suggesting that VC0179 synthesized c-di-AMP more efficiently than c-di-GMP. Prior to these results, only proteins containing GGDEF domains were thought to be able to produce c-di-GMP in bacteria (Ryjenkov et al., 2005) . We also tested whether VC0179 could enzymatically modify TTP, UTP, and CTP but did not detect significant activity (data not shown), suggesting that VC0179 preferentially uses purine nucleotide triphosphates as substrates.
Because VC0179 can use ATP and GTP substrates but appears to be more efficient in its use of ATP, we asked if it preferred one substrate to the other when given the option. We incubated VC0179 with equal molar amounts of GTP and ATP and analyzed the products by PAGE, HPLC, LCMS, and MS/MS. Remarkably, we found that the dominant reaction product migrated between c-di-AMP and c-di-GMP by PAGE ( Figures 3D and 3E ). This new product was observed in much greater amounts than either c-di-AMP or c-di-GMP as confirmed by HPLC (Figures 3F and 3I ). This suggested that VC0179 preferentially synthesizes a hybrid c-AMP-GMP molecule from ATP and GTP. High-resolution LCMS analysis confirmed that the mass of the VC0179 reaction product incubated with ATP and GTP was in agreement with a c-AMP-GMP molecule (Table S2 ; Figure S3 ). MS/MS was used to fragment this product into masses accurate for AMP and GMP, further confirming the hybrid structure (Table S3; Figure S4 ). As with ATP, the D131A/D133A VC0179 mutant protein did not produce any product when incubated with GTP or an ATP/GTP mixture ( Figure S5A ).
Given that in metabolically active cells there is a mixture of all NTPs, we tested the preference of VC0179 in a mixture that included equal amounts of all five NTPs. We again found that VC0179 produced substantially more of the hybrid c-AMP-GMP molecule than any other cyclic di-nucleotide ( Figure 3J ). To our knowledge, this is the first report of an enzyme that can produce a hybrid cyclic di-nucleotide and the first enzyme capable of producing three different cyclic di-nucleotides. Therefore, we have designated the product of VC0179 dinucleotide cyclase Vibrio or DncV. Using BLAST and ClustalW, we identified and align homologs that were at least 20% similar to DncV and had the conserved G[G/S]x 9-13 Dx[D/E] motif ( Figure S5B ). DncV homologs can be identified in a wide range of bacteria, several of which are pathogenic.
c-AMP-GMP Is the Dominate DncV Product In Vivo
Because DncV is capable of synthesizing three different cyclic di-nucleotides in vitro, we assayed its activity in vivo. We addressed this question using two systems. We first used a heterologous system to induce high-level expression of WT DncV or the D131A/D133A DncV mutant from a plasmid in E. coli. Analysis of cytosolic samples by LCMS showed a strong signal for c-AMP-GMP in E. coli expressing WT DncV, but not in E. coli expressing D131A/D133A DncV mutant (Table 2 ; Figures  S6A and S6B) . We also observed a c-di-AMP signal in E. coli expressing WT DncV but again not in E. coli expressing D131A/D133A DncV mutant (Table 2 ; Figures S6C and S6D) . We observed c-di-GMP in both WT and mutant DncV expressing E. coli that most likely represents endogenous production (data not shown). Thus, we cannot conclude that the c-di-GMP detected in this sample was a product of DncV under this condition.
We next examined cytosolic samples from a V. cholerae DdncV strain expressing WT DncV or D131A/D133A DncV mutant from an inducible plasmid. LCMS analysis identified c-AMP-GMP in the WT DncV-expressing strain, but not in the D131A/D133A DncV mutant-expressing strain (Table 2 ; Figure 4A) . Interestingly, we could not detect c-di-AMP or c-di-GMP in any of the V. cholerae samples. However, we cannot rule out that DncV does produce c-di-AMP and/or c-di-GMP in V. cholerae at levels below our detection limit. These results indicate that DncV can synthesize c-AMP-GMP and c-di-AMP in vivo but that c-AMP-GMP is the major product. Equal amounts of culture where processed for each sample, and total ion count analyzed for each sample is shown as an analysis control ( Figures S7A and S7B ). 
DncV Activity Modulates V. cholerae Chemotaxis and Does Not Affect c-di-GMP-Dependent Regulation
We did not notice a significant growth difference between V. cholerae WT and DdncV mutant strains in rich or minimal medium (data not shown). To determine biological effects of DncV expression, we used RNA-seq to compare the transcriptome profiles of a DdncV mutant and a DdncV mutant in which DncV expression was induced from a plasmid for 15 min. From this analysis we observed coordinated differential expression of groups of genes that clustered into four biological processes ( Figure 4B ; Table S4 ). The largest concerted regulatory effect showed that many chemotactic genes downregulated following DncV induction. Signal-transducing chemotactic proteins are known to bind purines (Stock et al., 1987) , suggesting that the products of DncV could directly interact and modulate the activity of these proteins. We tested the chemotactic abilities of the WT, DdncV mutant, and DdncV mutant expressing DncV from a plasmid using semisolid agar chemotaxis plates and found that increased expression of DncV severely inhibited V. cholerae chemotaxis ( Figure 4C ). We also found that expressing the DncV D131A/D133A mutant did not affect chemotaxis, indicating that the catalytic activity of DncV is required for this phenotype ( Figure 4C ). WT and D131A/D133A mutant proteins showed similar expression and degradation patterns following induction, indicating that the observed effects were not due to a difference in protein level ( Figure S7C ). Although we did not observe any changes in the expression of flagellum biogenesis genes, it is possible that the effect we observed on the semisolid agar was due to defects in flagellum biogenesis or function. To test this possibility, we extracted WT plus vector and DdncV mutant plus pDncV from the plate containing arabinose shown in Figure 4C and checked for motility. Phase-contrast microscopy showed that increased expression of DncV did not change overall motility of V. cholerae, agreeing with our transcriptome analysis that expression of flagellum components was unaffected (Movies S1 and S2). Interestingly, repressing chemotaxis has been shown to significantly enhance V. cholerae intestinal colonization (Butler et al., 2006) . Thus, expression of VC0179 may enhance colonization by suppressing chemotactic behavior.
We compared our transcriptome results to recently published microarray analysis of the regulatory effects of increased c-di-GMP production in V. cholerae (Beyhan et al., 2006) . The most prominent regulatory effects of increased c-di-GMP levels included increased expression of MSHA, the extracellular protein secretion system (EPS), and Vibrio polysaccharide (VPS) biogenesis genes, as well as decreased expression of flagellum biogenesis genes. In contrast our transcriptome analysis of DncV induction showed decreased expression of MSHA biosynthesis genes, and no effect on EPS, VPS, or flagellum biogenesis genes (Table S4) . Furthermore, increased c-di-GMP levels were shown to drastically reduce the number of motile bacterium and increase biofilm production (Beyhan et al., 2006) , whereas expression of DncV does not affect V. cholerae motility (Movies S1 and S2) or biofilm production (unpublished data). c-AMP-GMP is the dominant molecule produced by DncV in vivo ( Figures 4A and S6) . The lack of gene regulatory and phenotypic overlap between increased DncV expression and increased c-di-GMP levels suggests that c-AMP-GMP and c-di-GMP have different regulatory roles in the cell.
DISCUSSION
The VSP islands are the most pronounced genetic difference between classical and El tor strains of V. cholerae (Dziejman et al., 2002) ; however, any fitness benefit they offered El tor strains was unknown. Our results describe a multifaceted regulatory cascade driven by ToxT and mediated through the TCP island-encoded sRNA, TarB, that downregulates expression of VSP-1 transcription factor VspR ( Figure 5 ). Loss of VspR derepresses VSP-1 genes, including VC0179, which encodes a novel di-nucleotide cyclase, DncV, which is required for efficient V. cholerae intestinal colonization and regulates the colonization-influencing process of chemotaxis. DncV is the first reported enzyme capable of synthesizing c-di-AMP in Gram-negative bacteria and the first enzyme capable of synthesizing the previously undescribed hybrid c-AMP-GMP.
It was previously shown that VC0179 expression was upregulated in the rabbit intestine supporting a role for VC0179 in intestinal colonization (Xu et al., 2003) . The connection between induction of the master virulence regulator ToxT and VSP-1 regulation strongly suggested that genes encoded by VSP-1 were expressed in vivo and likely contribute to pathogenesis or other virulence-associated properties (e.g., transmission or infectivity). The association of VSP-1 with V. cholerae colonization offers the first evidence that the evolutionary success of V. cholerae El Tor strains carrying VSP-1 islands may have been driven by increased fitness within the host and, thus, implies that VSP-1 is indeed a pathogenicity island. It is possible that VSP-1 contributes to properties that might improve the fitness of 7 th pandemic El Tor strains of V. cholerae in the aquatic environment because some VSP-1 genes have been recently found in environmental non-O1, non-O139 V. cholerae strains . However, VSP-1 was universally present in TCP+ O1 and O139 strains Rahman et al., 2008) , suggesting that the regulatory linkage of the TCP and VSP-1 islands documented here may be selecting for their coinheritance in pathogenic 7 th pandemic strains.
Comparative genome analysis shows that DncV homologs are found in pathogenic islands of other disease-causing bacteria including the High Pathogenicity Island (HPI) of Enterobacteriaceae strains (Paauw et al., 2010; Schubert et al., 2004) . Interestingly, DncV homologs in HPI are often found associated with the closely neighboring VSP-1 gene VC0181. VC0181 is annotated as an integrative and conjugative element, suggesting that it may help DncV recombine into new genomes and genomic islands. There are additional VSP-1 genes that did not appear in our network that may also influence V. cholerae colonization. These genes might still be regulated by VspR, but our conditions may not have favored their expression. VspR might also play a regulator role outside of VSP-1 that future ChIP-seq analysis will illuminate. The neighboring gene, VC0176, is annotated as a putative CI/Cro-like regulator. Because VspR appears to affect VC0176 expression, there may be regulatory interplay between these two factors that modulates VSP-1 activity or other genes outside of the island. Further characterization of the hypothetical proteins encoded in VSP-1 and VSP-2 may offer significant Table S4 , and Movies S1 and S2. insights into differences into host adaptation of the 7 th pandemic El Tor lineage of
V. cholerae.
In bacteria, c-di-GMP is synthesized by proteins containing a GGDEF motif, which are found in the majority of bacterial genomes (Ryjenkov et al., 2005) . c-di-AMP is synthesized in Gram-positive bacteria by proteins containing the unrelated DUF147 domain (Witte et al., 2008) . Remarkably, the active site of DncV is able to produce both c-di-AMP and c-di-GMP compounds as well as a previously undescribed hybrid c-AMP-GMP. Our initial biochemical analysis suggests that DncV has a strong product preference for synthesis of c-AMP-GMP followed by c-di-AMP and c-di-GMP. These results agree with our finding that c-AMP-GMP is the dominant DncV product in vivo. Future structural analysis of DncV will be particularly interesting to determine its mode of substrate selection and catalytic action. Although DncV appears to have a product preference, the balance of product it produces in vivo would be heavily influenced by its local intracellular NTP concentration. Energetic shifts that alter the cytosolic ATP concentration could also impact DncV product production.
Cyclic nucleotides act as intracellular signals, modulating a range of cellular activities (Gomelsky, 2011) . In Gram-negative bacteria, c-di-GMP is a major regulator of biofilms (Tischler and Camilli, 2004) and flagellum biosynthesis (Lim et al., 2007) , and in Gram-positive bacteria, c-di-AMP reports on DNA integrity and cell membrane stress (Corrigan et al., 2011; Woodward et al., 2010) . Because DncV can produce both molecules, its activity may influence all of these processes. The hybrid c-AMP-GMP molecule may function in both c-di-GMP and c-di-AMP pathways and/or completely new processes specific to a hybrid interaction. Expression comparison showed that regulatory events mediated by DncV induction are not likely due to increased c-di-GMP levels. Increased expression of DncV strongly inhibits V. cholerae chemotaxis, but the bacteria are still highly motile. Interestingly, V. cholerae shed from humans show reduced expression of chemotaxis genes (Merrell et al., 2002) . Repression of chemotaxis is thought to contribute to a hyperinfectious state of V. cholerae, and indeed, repressing chemotaxis has been shown to significantly enhance V. cholerae intestinal colonization (Butler et al., 2006) . These observations suggest a mechanism for the necessity of DncV for efficient V. cholerae intestinal colonization. We propose that the in vivo environment induces ToxT activity that in turn results in derepression of DncV via the TarB-VspR pathway and an inhibition of chemotaxis via the accumulation of cyclic di-nucleotides. Reduced chemotaxis might not only stimulate colonization but also influence infectivity long after V. cholerae exits the ToxT-inducing environment of the small intestine (Butler et al., 2006; Merrell et al., 2002) .
Interestingly, DncV expression induced fatty acid catabolism and repressed fatty acid biosynthesis. Metabolomic analysis of cecal fluid harvested from V. cholerae-infected rabbits has recently revealed that the intestinal milieu contains high levels of long-chain fatty acids compared to laboratory medium (Mandlik et al., 2011) . Fatty acids were recently shown to modulate ToxT activity, and indeed, a 16-carbon fatty acid cis-palmitoleate crystallizes with ToxT when expressed and purified from E. coli (Lowden et al., 2010) . It will be interesting to investigate if DncV activity creates regulatory signals that modulate ToxT activity in vivo by specifically stimulating the breakdown of host lipids and transport of fatty acids. However, a role for cyclic di-nucleotides in regulating fatty acid metabolism has not yet been demonstrated in V. cholerae.
The association of DncV expression with ToxT activity suggests that the cellular concentration of c-di-AMP, c-di-GMP, and/or c-AMP-GMP may increase significantly when V. cholerae enters the host intestinal environment. Interestingly, c-di-AMP has recently been shown to be secreted by multidrug efflux pumps from L. monocytogenes (Woodward et al., 2010) . In the context of L. monocytogenes infection, c-di-AMP alters the mammalian host immune response (Woodward et al., 2010) , and recently cyclic di-nucleotides have been identified as key agonists of the STING innate immune signaling pathway (Burdette et al., 2011) . Purinergic receptors known to modulate pH and electrolyte secretion are found extensively on the apical membrane of intestinal epithelial cells where V. cholerae colonizes (Dho et al., 1992; Kaunitz and Akiba, 2011) . We are currently investigating whether V. cholerae may also secrete c-AMP-GMP and/or c-di-AMP as these cyclic di-nucleotides could interact with the host cell receptors to modulate intestinal cell electrophysiology or innate immunity. Such an effect could be beneficial to a range of intestinal pathogens that carry DncV homologs. Thus, secreted c-AMP-GMP and/or c-di-AMP could act as bacterial toxins that affect disease progression. The discovery of DncV-produced cyclic di-nucleotides adds another layer of complexity to V. cholerae pathogenesis and implicates these novel small molecules in the disease process.
EXPERIMENTAL PROCEDURES
ChIP-Seq and RNA-Seq ChIP, sample preparation, sequencing, and data processing were performed as previously described by Davies et al. (2011) . Experiments were repeated in quadruplicate. Samples were sequenced using the HeliScope Single Molecule Sequencer at the Molecular Biology Core Facility in the Dana-Farber Cancer Institute.
For ToxT expression studies RNA was converted to cDNA, and subsequent sample preparation and sequencing were performed as described for ChIPseq. For VC0179 expression studies RNA samples were processed for Illumina multiplex sequencing as described by the manufacturer. Sequencing data were aligned to the V. cholerae N16961 genome using CLC genomic workbench software using RPKM for expression values. The statistical test performed was a Baggerley's test on proportion of counts in each group of samples to generate a p value associated with the weighted proportion fold change between experiment and control groups for each gene. The result is a weighted t-type test statistic. We then used a cutoff of 4-fold weighted proportion absolute change with a FDR corrected p value of %0.01.
RP-HPLC, LCMS, and LC-MS/MS
Reverse-phase HPLC (RP-HPLC) was performed as previously described by Oppenheimer-Shaanan et al. (2011) . High-resolution LCMS analysis was performed on an Agilent 6520 Accurate-Mass Q-TOF mass spectrometer using an electrospray (ESI) ionization source in negative mode. Tandem MS/MS analysis was performed using collision-induced dissociation (CID). Ions were selected using a medium iso width (approximately 4 m/z) and CID energy set to 20. Parent masses and fragment ions are listed in Tables S2  and S3 .
In Vivo Detection of Cyclic Di-Nucleotides WT and D131A/D133A mutant VC0179 were expressed in BL21 E. coli or V. cholerae. Clarified cell supernatant was passed over a Waters Sep-Pak C18 cartridge by gravity flow. Bound material was eluted, resuspended in 50% acetonitrile, and analyzed by LCMS as described.
Di-Nucleotide Cyclase Assay
A total of 50 nM of VC0179-63His or D131A/D133A mutant VC0179-63His enzyme was incubated with the indicated NTPs at 37 C for the indicated time. Samples were processed for RP-HPLC, LCMS, MS/MS, or separated by denaturing PAGE and exposed to film. The animal experiments were performed with protocols approved by the Harvard Medical School Office for Research Protection Standing Committee on Animals.
ACCESSION NUMBERS
All previously unreported sequences have been uploaded as GEO study accession number GSE36373.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, two movies, and five tables and can be found with this article online at doi:10.1016/j.cell.2012.01.053.
